End-of-life decisions are often anything but easy. AI might be able to help. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

While there have been no reported injuries, a manufacturing error involving debris contamination could potentially kill a patient.

People are still asking if AI will replace doctors or other healthcare workers. 

Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

The insurance giant said it will link executive compensation to provider and patient satisfaction, in addition to releasing an annual transparency report on claims reimbursement and denials.

Journavax was shown in clinical trials to be safe and effective, with no addictive potential. 

Last week’s blastoff of the Chinese AI company DeepSeek struck many like a cold bucket of water in the face.